Friday 6 November 2026
Export CMT’s income statement to Excel — free account
Core Molding Technologies Inc
CMT Basic Materials Specialty Chemicals
Core Molding Technologies Inc’s revenue for fiscal 2025 (year ended December 2025) was $273.8 million, down 9.45% from fiscal 2024.
- Revenue
- +54.4%
- EPS
- −18.2%
- Free cash flow
- −3,170.5%
- Total debt
- −76.7%
Quarter to September 2026, against a year earlier
21.59
0.54
+2.57%
Follow CMT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
15.42 | 20.00 | 27.44 | 27.74 |
P/S ratio |
0.63 | 0.71 | 0.80 | 0.68 | |
P/FCF ratio |
89.62 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
34.23 | (20.81) | 12.42 | (52.76) | |
P/B ratio |
1.09 | 1.21 | 1.26 | 1.21 | |
Price to Tangible BV |
1.25 | 1.40 | 1.44 | 1.38 | |
EV/Sales |
0.56 | 0.69 | 0.82 | 0.69 | |
EV/EBITDA |
5.78 | 7.72 | 9.79 | 9.93 | |
EV/Operating CF |
8.00 | 48.70 | 12.58 | 23.46 | |
EV/FCF |
80.05 | (12.18) | (25.25) | (10.21) | |
Quick Ratio |
2.21 | 1.76 | 1.19 | 1.09 | |
Current Ratio |
3.02 | 2.41 | 2.00 | 1.86 | |
Net Debt/EBITDA |
(2.85) | (1.11) | (2.22) | (0.15) | |
Debt/Assets |
8.64% | 7.95% | 0.00% | 2.08% | |
Debt/Equity |
0.12 | 0.12 | 0.00 | 0.03 | |
Asset Turnover |
1.25 | 1.16 | 1.14 | 1.27 | |
Operating CF/Net income |
1.63 | (15.25) | 9.14 | (2.45) | |
Capex/Depreciation |
(2.80) | (1.24) | (2.61) | (3.03) | |
Interest Coverage |
— | 8.88 | 38.25 | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.38% | 19.14% | 16.63% | 13.07% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.19% | 0.84% | 0.80% | 0.58% | |
Graham Net Nets |
0.19 | 0.17 | 0.15 | 0.14 | |
Graham Number |
23.24 | 21.56 | 19.06 | 18.61 | |
Earnings Yield |
6.48% | 5.00% | 3.64% | 3.60% | |
Free Cash Flow Yield |
1.12% | (8.03%) | (4.10%) | (9.87%) | |
Revenue per Share |
8.71 | 6.83 | 7.31 | 10.52 | |
Operating CF per Share |
0.59 | (1.08) | 1.90 | (0.43) | |
Capex per Share |
(0.93) | (0.44) | (0.97) | (0.89) | |
Free Cash Flow per Share |
(0.34) | (1.52) | 0.93 | (1.32) | |
Cash per Share |
4.44 | 2.74 | 1.41 | 0.63 | |
Shareholders Equity per Share |
18.46 | 18.45 | 18.77 | 18.78 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.46 | 18.45 | 18.77 | 18.78 | |
Free Cash Flow |
(2.94) | (13.01) | 8.00 | (11.32) | |
Working Capital |
69.16 | 68.57 | 48.07 | 45.05 | |
Capital Expenditures |
(7.96) | (3.78) | (8.30) | (7.62) | |
Net Current Asset Value |
33.37 | 32.94 | 29.96 | 27.52 | |
EV/EBIT |
10.79 | 15.47 | 22.73 | 23.88 | |
Capex to Sales |
0.11 | 0.06 | 0.13 | 0.08 | |
Price to Operating Income |
12.08 | 15.82 | 21.95 | 23.69 | |
| Other line items | |||||
Average Receivables |
36.69 | 51.47 | 44.35 | 46.25 | |
Average Payables |
16.02 | 23.00 | 23.22 | 24.90 | |
Average Inventory |
19.03 | 20.86 | 23.35 | 23.25 | |
Average Assets |
218.84 | 232.97 | 223.67 | 225.33 | |
Average Common Equity |
152.77 | 154.05 | 157.27 | 158.29 |
Columns are period end dates · fundamentals updated 4 Nov 2026